Cochrane Review Group
Hepato-Biliary
132 systematic reviews in Hepato-Biliary ask 1,521 questions. 19.9% have no studies to answer them, 57.6% rest on very low certainty evidence and 5.7% reach moderate or high certainty.
Reviews
132
Questions
1,521
current versions
No studies
19.9%
Moderate or high
5.7%
No studies 303 · 19.9%Ungraded 39 · 2.6%Very low 876 · 57.6%Low 216 · 14.2%Moderate 65 · 4.3%High 22 · 1.4%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Microwave coagulation in addition to conventional transarterial chemoembolisation vs conventional transarterial chemoembolisation alone All‐cause mortality · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | no estimate extracted | NR | No studies |
Microwave coagulation vs conventional surgery Health‐related quality of life · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | no estimate extracted | NR | No studies |
Microwave coagulation vs conventional surgery Any adverse events or complications · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | no estimate extracted | 1 study · 30 participants | Very low |
Microwave coagulation vs conventional surgery Disease‐free survival · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | no estimate extracted | 1 study · 30 participants | Very low |
Microwave coagulation vs conventional surgery Failure to clear liver metastases · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | no estimate extracted | NR | No studies |
Microwave coagulation vs conventional surgery Recurrence of liver metastases · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | no estimate extracted | NR | No studies |
Microwave coagulation vs radiofrequency ablation All‐cause mortality · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | RR 0.62 [0.26, 1.47] | 1 study · 50 participants | Very low |
Microwave coagulation vs radiofrequency ablation Time to mortality (overall survival) · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | HR 0.63 [0.23, 1.73] | 1 study · 50 participants | Very low |
Microwave coagulation vs radiofrequency ablation Health‐related quality of life · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | no estimate extracted | NR | No studies |
Microwave coagulation vs radiofrequency ablation Any adverse events or complications · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | RR 0.19 [0.01, 3.67] | 1 study · 50 participants | Very low |
Microwave coagulation vs radiofrequency ablation Disease‐free survival · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | no estimate extracted | NR | No studies |
Microwave coagulation in addition to conventional transarterial chemoembolisation vs conventional transarterial chemoembolisation alone Time to mortality · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane | no estimate extracted | NR | No studies |
Reviews 132
Lifestyle modifications for nonalcohol‐related fatty liver disease: a network meta‐analysis
CochraneSoF table
15 questions
Nutritional supplementation for nonalcohol‐related fatty liver disease: a network meta‐analysis
CochraneSoF table
48 questions
Abdominal ultrasound and alpha‐foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
CochraneSoF table
6 questions
Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
CochraneSoF table
2 questions
Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis
CochraneSoF table
24 questions
Percutaneous ethanol injection for liver metastases
CochraneSoF table
7 questions
Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases
CochraneSoF table
21 questions
Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma
CochraneSoF table
21 questions
Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
CochraneSoF table
8 questions
N‐acetylcysteine for non‐paracetamol (acetaminophen)‐related acute liver failure
CochraneSoF table
12 questions
Treatment for ascites in adults with decompensated liver cirrhosis: a network meta‐analysis
CochraneSoF table
32 questions
Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta‐analysis
CochraneSoF table
23 questions
Induction immunosuppression in adults undergoing liver transplantation: a network meta‐analysis
CochraneSoF table
26 questions
Glucocorticosteroids for people with alcoholic hepatitis
CochraneSoF table
6 questions
Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis
CochraneSoF table
13 questions
Cryotherapy for liver metastases
CochraneSoF table
7 questions
Acetyl‐L‐carnitine for patients with hepatic encephalopathy
CochraneSoF table
7 questions
Transcatheter arterial chemoembolisation followed by three‐dimensional conformal radiotherapy versus transcatheter arterial chemoembolisation alone for primary hepatocellular carcinoma in adults
CochraneSoF table
8 questions
Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis
CochraneSoF table
11 questions
Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices
CochraneSoF table
7 questions
Radix Sophorae flavescentis versus no intervention or placebo for chronic hepatitis B
CochraneSoF table
7 questions
Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B
CochraneSoF table
8 questions
Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta‐analysis
CochraneSoF table
16 questions
Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B
CochraneSoF table
8 questions
Acupuncture for chronic hepatitis B
CochraneSoF table
7 questions